Our Team

Dr Lou Aurelio is a seasoned synthetic and analytical organic chemist with decades of experience in compound design, process development, and analytical instrumentation. He has a proven record of taking ideas from the lab bench to commercial production – designing, optimising, and scaling routes for novel APIs and advanced intermediates.

As the former CEO of ADKL Labs, Lou led multidisciplinary teams delivering end-to-end contract research programs while establishing new laboratory facilities and corporate operations. Earlier in his career, he served as a Senior Research Fellow at Monash University, contributing to cutting-edge medicinal and process chemistry research and building a strong publication record.

Lou has played a key role in the commercialisation of innovative synthetic routes for non-natural amino acids and lead candidate optimisation for several Australian biotech companies, including VAST Biosciences, Ena Respiratory, and Axelia. He has also supported the large-scale synthesis of lead compounds for Cincera, Ankere, and Amplia.

Known for his clear communication, rigorous documentation, and strategic insight, Lou bridges the gap between discovery and delivery. At Neuraform, he leads client engagements and technical solutions for new synthesis projects, ensuring scientific excellence and commercial impact.

Originally from Italy, Dr Lorenzo Carli continued his scientific journey through Germany before moving to Australia. Here, he completed his PhD in Organic Chemistry at Monash University, where he investigated new photo-, organo-, and transition-metal asymmetric catalytic pathways.

Dr Carli’s international research experience has focused on multi-step synthetic routes and method development across natural product synthesis, photochemistry, organometallic chemistry, and asymmetric synthesis. Building on this academic foundation, he transitioned into industrial R&D, pursuing route scouting and multi-kilo-scale-up projects for the Australian chemical manufacturing sector. He has worked with a range of industrial-scale batch and flow reactor setups, managed small production teams in ISO 9001-compliant environments, and collaborated closely with clients to deliver innovative, high-quality results.

With over eight years of experience spanning academic and industrial settings – and a strong commitment to safety, quality, and client-centred outcomes – Dr Carli joined Neuraform in 2025 as a Medicinal/Synthetic Chemist. In this role, he applies his diverse expertise to advance the development of novel therapeutic compounds.